New inhaled antifungal shows promise for lung transplant patients
Disease control
Completed
This study tested a new drug called opelconazole, given as a mist through a nebulizer, to prevent a serious fungal lung infection (aspergillosis) in people who had a lung transplant. The trial involved 102 participants and compared the drug to standard care. The main goal was to …
Phase: PHASE2 • Sponsor: Pulmocide Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC